Shanghai Rightongene Biotechnology Co. Ltd. Class ASSE: 688217

Announcement on Convening the 2025 Annual Performance Briefing

· Issued by Shanghai Rightongene Biotechnology Co. Ltd. Class A via Shanghai Stock Exchange
Announcement on Convening the 2025 Annual Performance Briefing

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

Earlier from Shanghai Rightongene Biotechnology Co. Ltd. Class A

All Shanghai Rightongene Biotechnology Co. Ltd. Class A news releases